Performance Updates - 开拓药业-B (09939.HK) has completed patient enrollment for the Phase III clinical trial of KX-826 solution for androgenetic alopecia in adult males in China [2] - 李氏大药厂 (00950.HK) has received approval from the National Medical Products Administration for Socazolimab to be used in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer in mainland China [2] - 恒瑞医药 (01276.HK) has received approval for clinical trials of SHR-8068 injection, Adebali monoclonal antibody injection, and Bevacizumab injection [2] - 恒瑞医药 (01276.HK) has also received approval to conduct clinical trials for HRS-5041, intended for prostate cancer treatment [2] - 深圳高速公路股份 (00548.HK) reported toll revenue of 106 million yuan for the outer ring project in June [2] - 大成生化科技 (00809.HK) has signed an EPC contract with Northeast Electric and Liaoning Electric for boiler renovation projects, with a maximum cost of 129.1 million yuan [2] - 小黄鸭德盈 (02250.HK) has signed a contract to develop an AI marketing system to diversify revenue sources [2] Buyback and Financing Activities - 威海银行 (09677.HK) plans to issue up to approximately 758 million domestic shares and 154 million H-shares, raising nearly 3 billion yuan [2] Financial Results - 香港电讯-SS (06823.HK) reported total revenue of 17.322 billion HKD for the first half, a year-on-year increase of 4%, with a net profit of 2.07 billion HKD, also up 4% [4] - 青岛银行 (03866.HK) reported operating revenue of 7.662 billion yuan for the first half, a growth of 7.5%, and a net profit of 3.065 billion yuan, up 16.05% [4] - 中国石油化工股份 (00386.HK) expects mid-term net profit to be between 20.1 billion and 21.6 billion yuan, a year-on-year decline of 39.5%-43.7% [4] - 汽车之家-S (02518.HK) reported total revenue of 3.212 billion yuan for the first half, a decrease of 7.75%, with a net profit of 772 million yuan, down 15.99% [4] - 绿茶集团 (06831.HK) issued a profit warning, expecting mid-term net profit to be between 230 million and 237 million yuan, a year-on-year increase of approximately 32%-36% [4] - 粤海置地 (00124.HK) issued a profit warning, expecting mid-term net profit to exceed 260 million HKD, turning from loss to profit [4] - 药师帮 (09885.HK) issued a profit warning, expecting mid-term net profit to exceed 70 million yuan [4] - 中国东方教育 (00667.HK) issued a profit warning, expecting mid-term net profit to grow by 45%-50% year-on-year [4] - 中核国际 (02302.HK) issued a profit warning, expecting mid-term revenue to increase to at least 585 million HKD, with net profit of at least 9.5 million HKD [4] - 大唐环境 (01272.HK) issued a profit warning, expecting mid-term net profit to decrease to between 350 million and 400 million yuan [4] - 长江生命科技 (00775.HK) issued a profit warning, expecting mid-term net loss of approximately 150 million HKD, turning from profit to loss year-on-year [4] - 延长石油国际 (00346.HK) issued a profit warning, expecting mid-term loss of approximately 27.9 million HKD [4]

智通财经APP讯，小黄鸭德盈(02250)发布公告，于2025年7月29日，公司间接全资附属公司森科产品有 限公司(森科产品)与科案有限公司(科案，连同森科产品，统称订约方)签订了一份服务协议。根据服务 协议，订约方已同意就共同投资、开发及商业化一项具备基于网页界面的人工智能(AI)驱动营销情报与 内容自动化系统(该项目)展开合作。 （原标题：小黄鸭德盈(02250)附属签约开发AI营销系统 拓新收益来源） 公告称，与科案签订服务协议将实现以下战略价值：透过将集团知识产权转化为 AI 驱动营销/内容解决 方案，开拓新市场及收益来源;同时保障核心数据资产，并获取可观的财务效益与竞争优势。 ...

小黄鸭德盈(02250)发布公告，自2025年8月1日起： 1.黄颍钊先生已辞任首席财务官; 3.宋治强先生将由独立非执行董事调任为执行董事及获委任为首席财务官、公司秘书及授权代表，并将 不再担任审核委员会主席以及提名委员会与薪酬委员会成员; 4.吴迪先生获委任为独立非执行董事、审核委员会主席及薪酬委员会成员;及 5.独立非执行董事梁丙焄女士获委任为提名委员会成员。 2.麦玉娇女士已辞任公司秘书及授权代表; ...

Core Viewpoint - The company, Little Yellow Duck De Ying (02250), has signed a service agreement with Kaan Limited through its indirect wholly-owned subsidiary, Senke Products Limited, to jointly invest, develop, and commercialize an AI-driven marketing intelligence and content automation system by July 29, 2025 [1] Group 1 - The service agreement aims to transform the company's intellectual property into AI-driven marketing and content solutions, thereby opening new markets and revenue streams [1] - The collaboration is expected to safeguard core data assets while providing significant financial benefits and competitive advantages [1]

科案将负责开发AI架构，包括用于跨社交平台数据收集的外部AI代理、即时市场分析的AI模型、具备 内容创作与A/B测试功能的AI贴文生成模组及执行效能监控与反馈回路自动化的内部AI代理。森科产品 将提供品牌专属数据、设定营销内容语境、支援解决方案在相关数位渠道的整合、协助制定测试策略及 评估受众对AI生成内容的反应以支持商业决策。 董事会认为，与科案签订服务协议将实现以下战略价值：透过将集团知识产权转化为AI驱动营销/内容 解决方案，开拓新市场及收益来源；同时保障核心数据资产，并获取可观的财务效益与竞争优势。 格隆汇7月31日丨小黄鸭德盈(02250.HK)公告，于2025年7月29日，公司间接全资附属公司森科产品有限 公司与科案有限公司签订了一份服务协议。根据服务协议，订约方已同意就共同投资、开发及商业化一 项具备基于网页界面的人工智能（AI）驱动营销情报与内容自动化系统展开合作。 服务协议确立森科产品与科案就该项目合作的基本原则。该项目旨在构建端到端人工智能驱动解决方 案，通过整合中央内容管理系统（CMS）界面的外部与内部AI代理，实现社交数据收集、情感分析、 内容生成及受众测试的流程优化。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負 責，對其準確性或完整性亦不發表任何聲明，幷明確表示概不就因本公告全部或 任何部分內容而産生或因倚賴該等內容而引致之任何損失承擔任何責任。 B.Duck Semk Holdings International Limited 小黃鴨德盈控股國際有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰2250） 自願性公告 ─ 簽訂服務協議 本公告乃小黃鴨德盈控股國際有限公司（「本公司」，連同其附屬公司，「本集 團」）自願作出，以使其股東及潛在投資者了解本集團的最新業務發展。 本公司董事（「董事」）會（「董事會」）欣然宣布，於 2025 年 7 月 29 日（「簽 署日期」），本公司間接全資附屬公司森科產品有限公司（「森科產品」）與科 案有限公司（「科案」，連同森科產品，統稱「訂約方」，各自稱「訂約方」） 簽訂了一份服務協議（「服務協議」）。根據服務協議，訂約方已同意就共同投 資、開發及商業化一項具備基於網頁界面的人工智能（「AI」）驅動營銷情報與 內容自動化系統（「該項目」）展開合作。 服務協議 服務協議的主要條款如下： (ii) 科案 - ...

4.吴迪先生获委任为独立非执行董事、审核委员会主席及薪酬委员会成员;及 5.独立非执行董事梁丙焄女士获委任为提名委员会成员。 智通财经APP讯，小黄鸭德盈(02250)发布公告，自2025年8月1日起： 1.黄颍钊先生已辞任首席财务官; 2.麦玉娇女士已辞任公司秘书及授权代表; 3.宋治强先生将由独立非执行董事调任为执行董事及获委任为首席财务官、公司秘书及授权代表，并将 不再担任审核委员会主席以及提名委员会与薪酬委员会成员; ...

格隆汇7月31日丨小黄鸭德盈(02250.HK)公告，董事会谨此宣布自2025年8月1日起：1.黄颍钊已辞任首 席财务官；2.麦玉娇已辞任公司秘书及授权代表；3.宋治强将由独立非执行董事调任为执行董事及获委 任为首席财务官、公司秘书及授权代表，并将不再担任审核委员会主席以及提名委员会与薪酬委员会成 员；4.吴迪获委任为独立非执行董事、审核委员会主席及薪酬委员会成员；及5.独立非执行董事梁丙焄 获委任为提名委员会成员。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負 責，對其準確性或完整性亦不發表任何聲明，幷明確表示概不就因本公告全部或 任何部分內容而産生或因倚賴該等內容而引致之任何損失承擔任何責任。 B.Duck Semk Holdings International Limited 小黃鴨德盈控股國際有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰2250） 董事調任、 變更首席財務官、公司秘書及授權代表、 委任獨立非執行董事 及 變更董事會委員會組成 董事會謹此宣佈自 2025 年 8 月 1 日起： 董事會謹藉此機會感謝黃先生及麥女士於任內對董事會所作出的寶貴貢獻。 宋先生及吳先生各自的履歷詳情載列如下： 宋治強先生 宋治強先生，50 歲，於 2021 年 12 月 20 日獲委任為獨立非執行董事，並將於 2025 年 8 月 1 日起獲調任為執行董事，同時出任首席財務官、公司秘書及授權代 表。宋先生於財務管理、會計稅務、審計和企業融資方面擁有豐富經驗，曾於畢 馬威會計師事務所、羅兵咸永道會計師事務所及德勤企業財務顧問有限公司任職。 彼自 2024 年 2 月至 2025 年 7 月為華 ...

Company News - China Railway Construction (01186.HK) reported a new contract amount of approximately 1,056.17 billion yuan for the first half of the year, a year-on-year decrease of 4.04% [2] - China Metallurgical Group (01618.HK) announced a new contract amount of 548.2 billion yuan for the first half of the year, down 19.1% year-on-year [2] - Sichuan Chengyu Expressway (00107.HK) won the bid for the G5 Jingkun Expressway Chengdu to Ya'an section expansion project, with a total investment of approximately 28.548 billion yuan [2] - Road King Infrastructure (01098.HK) reported total property sales of 5.232 billion yuan for the first half of the year, a decrease of 28.37% year-on-year [2] - Amax Holdings (00880.HK) plans to acquire a property in Hengqin for 724.2 million yuan to diversify its business portfolio [2] - Chaoyue Eye Hospital (02219.HK) signed a construction contract for the first phase of its comprehensive medical facility project, with a contract value of 223 million yuan [2] - Bay Area Development (00737.HK) reported total toll revenue of 243 million yuan for June, a year-on-year decrease of 4% [2] - Decent Pharmaceuticals-B (06996.HK) received approval for its drug, Hivio®, for the second-line treatment of multiple myeloma in China [2] - Tianchen Holdings (01201.HK) plans to invest 30 million yuan to establish a joint venture in Shenzhen for new energy heavy truck charging stations [2] Performance Summary - WuXi AppTec (02359.HK) reported mid-year revenue of 20.799 billion yuan, a year-on-year increase of 20.64%, and a net profit of 8.561 billion yuan, up 101.92% year-on-year [3] Earnings Announcements - China Nonferrous Mining (01258.HK) issued a profit warning, expecting mid-term net profit of approximately 258 million USD, a year-on-year increase of about 18% [4] - Hualing Pharmaceutical-B (02552.HK) issued a profit warning, expecting mid-term net profit of approximately 1.184 billion yuan, turning from loss to profit [4] - Little Yellow Duck (02250.HK) issued a profit warning, expecting mid-term revenue to increase by over 30% year-on-year [4] - Qingci Games (06633.HK) issued a profit warning, expecting mid-term net profit to increase by approximately 78%-130% year-on-year [4] - Goodbaby International (01086.HK) issued a profit warning, expecting mid-term net profit to decrease by approximately 40%-50% year-on-year [4] - Qianhai Health (00911.HK) issued a profit warning, expecting mid-term net profit to decrease by approximately 60%-70% year-on-year [4] - Tianan Health (00383.HK) issued a profit warning, expecting mid-term net profit to decrease to approximately 7 million to 17 million HKD [4] - Pacific Network (00543.HK) issued a profit warning, expecting mid-term net loss of approximately 5 million to 15 million yuan [4] Buyback and Increase Dynamics - HSBC Holdings (00005.HK) repurchased 348,700 shares for approximately 35.487 million HKD at a price of 101.4-102 HKD [3] - China Eastern Airlines (00670.HK) repurchased 2.5 million shares for approximately 7.4983 million HKD at a price of 2.97-3.03 HKD [3] - Founder Holdings (00418.HK) canceled a total of 17.9962 million shares that had been repurchased [3]